Manufacturer savings cards are typically unavailable to patients with government insurance
Type 2 diabetes mellitus (DM2) affects a 13.8% of the Spanish population1 and its prevalence is expected to increase in the future.2 The presence of DM2 increases significantly the risk of cardiovascular events, chronic kidney disease (CKD), and premature death3,4 and as its prevalence increases it is expected to rise the incidence of microvascular and macrovascular complications.5 Until the last decade, the control of blood glucose, blood pressure, dyslipidemia, and the use of inhibitors of the renin-angiotensin system (iSRA) have been the only strategies available to reduce cardiovascular and renal risk in this population
What experts say about peptides and long-term safety We dont know enough about injectable peptides to say what kinds of effects they may have on long-term health or safety
Proposed Mechanisms of BPC-157 Animal and laboratory data suggest that BPC-157 may: Stimulate angiogenesis , promoting new blood vessel formation to improve nutrient delivery to injured tissues
However, this perspective has shifted with the development of new, highly effective drugs that are safe and accessible for a wider population